Back to RecallTracker
Health Canada Health products

Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium

Issued April 29, 2020
Issue
There is an unprecedented demand and shortage of Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, Health Canada has added US-labelled Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) vials in a 10 mL volume to the List of Drugs for Exceptional Importation and Sale in accordance with the Interim Order .
Hazard description
Product safety